Barbosa, Eduardo José 
; Gubitoso, Mariana Ribeiro; Bou-Chacra, Nadia Araci ; Byrn, Stephen R; Carvalho, Flavio Machado de Souza ; Araujo, Gabriel Lima Barros de
Fonte: ChemRxiv. Unidades: FCF, IGC
Assuntos: ANTI-HELMÍNTICOS, CORONAVIRUS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Eduardo José et al. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses. ChemRxiv, 2020Tradução . . Disponível em: https://doi.org/10.26434/chemrxiv.12056187. Acesso em: 15 jun. 2024.APA
Barbosa, E. J., Gubitoso, M. R., Bou-Chacra, N. A., Byrn, S. R., Carvalho, F. M. de S., & Araujo, G. L. B. de. (2020). Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses. ChemRxiv. doi:10.26434/chemrxiv.12056187NLM
Barbosa EJ, Gubitoso MR, Bou-Chacra NA, Byrn SR, Carvalho FM de S, Araujo GLB de. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses [Internet]. ChemRxiv. 2020 ;[citado 2024 jun. 15 ] Available from: https://doi.org/10.26434/chemrxiv.12056187Vancouver
Barbosa EJ, Gubitoso MR, Bou-Chacra NA, Byrn SR, Carvalho FM de S, Araujo GLB de. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses [Internet]. ChemRxiv. 2020 ;[citado 2024 jun. 15 ] Available from: https://doi.org/10.26434/chemrxiv.12056187
